Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients

The clinical state of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been considered a pandemic disease (COVID-19) that is rapidly spreading worldwide. Despite all global efforts, the only treatment for COVID-19 is supportive care and there has been no efficient treatment to fight...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeinivand, Motahareh, Sharifi, Masoomeh, Hassanshahi, Gholamhossein, Nedaei, Seyed Ershad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227407/
https://www.ncbi.nlm.nih.gov/pubmed/37273802
http://dx.doi.org/10.1007/s10989-023-10516-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227407/
https://www.ncbi.nlm.nih.gov/pubmed/37273802
http://dx.doi.org/10.1007/s10989-023-10516-3

Ejemplares similares